Drug recall · September 2, 2015
Amlodipine besylate and Atorvastatin calcium Tablets recall
Why: Subpotent Drug: Subpotent atorvastatin.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Amlodipine besylate and Atorvastatin calcium Tablets, 2.5 mg/20 mg, 30 Count Bottles, Rx Only. Manufactured by Dr. Reddy's Laboratories Limited, Bachupally - 500 090 India. NDC: 43598-320-30.
- Lots / codes
Lot #: C403574, Expiry: 10/2015
- Quantity
- 576 Bottles
- Company
- Dr. Reddy's Laboratories, Inc., Princeton, NJ
- Distribution
- U.S. Nationwide
- Initiated
- August 13, 2015 · Voluntary: Firm initiated
- Classified
- August 27, 2015
- Reported
- September 2, 2015
- Ended
- December 15, 2016
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Atorvastatin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.